EXECUTIVE ENGAGEMENTS
OUTREACH
2201
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
396
Interactions with Platform & by Email
PARTICIPANTS
66
Unique # Participated
VALIDATIONS
31
Responses Validated*
COMPETITORS
41
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
68
PAGES
139
EDITION
6
PRICE
USD $4950
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Infection Surveillance Solutions estimated at US$391.3 Million in the year 2020, is projected to reach a revised size of US$946.9 Million by 2027, growing at aCAGR of 13.5% over the period 2020-2027. Software, one of the segments analyzed in the report, is projected to record 13.2% CAGR and reach US$600.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 14% CAGR for the next 7-year period.
The Infection Surveillance Solutions market in the U.S. is estimated at US$115.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$165.4 Million by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.8% and 11.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.
SELECT PLAYERS
Atlas Medical Software; Baxter International, Inc.; Becton, Dickinson and Company; Deb Group Ltd.; Gojo Industries, Inc.; Hygreen, Inc.; Premier, Inc.; Rl Solutions; Truven Health Analytics
SEGMENTS
» End-Use (Hospitals, Long-term Care Facilities, Other End-Uses) » Product (Software, Services)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Infection Surveillance Solutions Market on a Rapid Growth Trajectory |
| Cloud-based Infection Surveillance Solutions Witness Increased Demand |
| Asia-Pacific to be Fastest Growing Region, Driven by Increasing Cases of HAIs |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Growing Incidence of HAIs, and Government Measures to Control them Drive the Growth of Infection Surveillance Solutions Market |
| Increasing Emphasis on Controlling Healthcare Expenditure Propels the Infection Surveillance Solutions Market |
| Rise in Number of Surgeries to Increase the Chances of HAI, thereby Driving the Demand for Infection Surveillance Solutions |
| Increasing Automation in Healthcare Units Offer Significant Opportunities for Market Growth |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Long-term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Long-term Care Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Active Players in United States |
| USA Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| USA Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| CANADA |
| Active Players in Canada |
| Canada Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| JAPAN |
| Active Players in Japan |
| Japan Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| CHINA |
| Active Players in China |
| China Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| China Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| FRANCE |
| Active Players in France |
| France Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| France Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| GERMANY |
| Active Players in Germany |
| Germany Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| ITALY |
| Active Players in Italy |
| Italy Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| UNITED KINGDOM |
| Active Players in United Kingdom |
| UK Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| UK Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| REST OF EUROPE |
| Active Players in Rest of Europe |
| Rest of Europe Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Active Players in Asia-Pacific |
| Asia-Pacific Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| REST OF WORLD |
| Active Players in Rest of World |
| Rest of World Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 41 |
The World of Infection Surveillance Solutions is Changing Fast!
It's Time to Identify Upcoming Revenue Pockets & Growth Areas.
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com